Subsequent stratification by molecular subtype revealed that elevated LRRN1 expression was associated with favorable survival outcomes in Luminal A and triple-negative breast cancer (TNBC) subtypes, whereas no statistically significant associations were observed in Luminal B or HER2-enriched subtypes (Figure 3A). The gene discussed is LRRN1; the disease is triple-negative breast carcinoma.